Cargando…

Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy

PURPOSE: Everolimus only inhibits mammalian target of rapamycin complex 1 (mTORC1), whereas Ku0063794 inhibits both mTORC1 and mTORC2. Although they have similar anticancer effects, their combination has a synergistic effect against hepatocellular carcinoma (HCC) cells. We aimed to determine the mec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sang Chul, Kim, Kee-Hwan, Kim, Ok-Hee, Lee, Sang Kuon, Hong, Ha-Eun, Choi, Byung Jo, Jeong, Wonjun, Kim, Say-June
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056969/ https://www.ncbi.nlm.nih.gov/pubmed/29121714 http://dx.doi.org/10.4143/crt.2017.085

Ejemplares similares

Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells
por: Jeon, Ye-Won, et al.
Publicado: (2022)

Combining Everolimus and Ku0063794 Promotes Apoptosis of Hepatocellular Carcinoma Cells via Reduced Autophagy Resulting from Diminished Expression of miR-4790-3p
por: Choi, Ho Joong, et al.
Publicado: (2021)

Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells
por: Kim, Jong-Ok, et al.
Publicado: (2016)

HSP90 inhibitor 17-DMAG exerts anticancer effects against gastric cancer cells principally by altering oxidant-antioxidant balance
por: Kim, Jeong Goo, et al.
Publicado: (2017)

Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
por: García-Martínez, Juan M., et al.
Publicado: (2009)

Does Korea's current diagnosis-related group-based reimbursement system appropriately classify appendectomy patients?
por: Kim, Kee-Hwan, et al.
Publicado: (2016)

Determination of optimized oxygen partial pressure to maximize the liver regenerative potential of the secretome obtained from adipose-derived stem cells
por: Lee, Sang Chul, et al.
Publicado: (2017)

Potent Dual Inhibitors of TORC1 and TORC2 Complexes (KU-0063794 and KU-0068650) Demonstrate In Vitro and Ex Vivo Anti-Keloid Scar Activity
por: Syed, Farhatullah, et al.
Publicado: (2013)

IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression
por: Lee, Sang Chul, et al.
Publicado: (2015)

A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models
por: Zhang, Hao, et al.
Publicado: (2013)

The feasibility of single-port laparoscopic appendectomy using a solo approach: a comparative study
por: Kim, Say-June, et al.
Publicado: (2016)

Lipopolysaccharide preconditioning of adipose-derived stem cells improves liver-regenerating activity of the secretome
por: Lee, Sang Chul, et al.
Publicado: (2015)

The utility of the preoperative neutrophil-to-lymphocyte ratio in predicting severe cholecystitis: a retrospective cohort study
por: Lee, Sang Kuon, et al.
Publicado: (2014)

A novel single-port laparoscopic operation for colorectal cancer with transanal specimen extraction: a comparative study
por: Kim, Say-June, et al.
Publicado: (2015)

FOXL2 directs DNA double-strand break repair pathways by differentially interacting with Ku
por: Jin, Hanyong, et al.
Publicado: (2020)

Harnessing adipose-derived stem cells to release specialized secretome for the treatment of hepatitis B
por: Kim, Hee Ju, et al.
Publicado: (2021)

Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
por: Lim, Taekyu, et al.
Publicado: (2011)

A rare collision tumor comprising intracystic papillary neoplasm associated with adenocarcinoma and angiosarcoma in the gallbladder
por: Park, Geon, et al.
Publicado: (2020)

Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation
por: Lee, Jaeim, et al.
Publicado: (2019)

Impact of obesity on the short-term outcomes of single-port laparoscopic colectomy for colorectal cancer in the Asian population: A retrospective cohort study
por: Choi, Byung Jo, et al.
Publicado: (2017)

Ku-Band 50 W GaN HEMT Power Amplifier Using Asymmetric Power Combining of Transistor Cells
por: Kim, Seil, et al.
Publicado: (2018)

Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori
por: Yun, Sang-Pil, et al.
Publicado: (2012)

Serum level of visfatin can reflect the severity of inflammation in patients with acute cholecystitis
por: Park, Jae Woo, et al.
Publicado: (2020)

A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer
por: Sun, J M, et al.
Publicado: (2013)

Laparoscopic Nissen Fundoplication in Korean Patients with Gastroesophageal Reflux Disease
por: Lee, Sang Kuon, et al.
Publicado: (2009)

Fibrous Plaque of the Eyelid in a Patient with Tuberous Sclerosis Responding to Everolimus
por: Park, Sung-Min, et al.
Publicado: (2018)

Immune-Enhancing Effect of Heat-Treated Levilactobacillus brevis KU15159 in RAW 264.7 Cells
por: Hwang, Chang-Hoon, et al.
Publicado: (2022)

Cross-sectional analysis of immunosuppressive regimens focused on everolimus after liver transplantation in a Korean high-volume transplantation center
por: Kang, Sang-Hyun, et al.
Publicado: (2019)

Combination of everolimus and tacrolimus: a potentially effective regimen for recalcitrant psoriasis
por: Wei, Kai-Che, et al.
Publicado: (2015)

In Vivo Evaluation of Immune-Enhancing Activity of Red Gamju Fermented by Probiotic Levilactobacillus brevis KU15154 in Mice
por: Park, Eunju, et al.
Publicado: (2021)

Erratum: Fibrous Plaque of the Eyelid in a Patient with Tuberous Sclerosis Responding to Everolimus
por: Park, Sung-Min, et al.
Publicado: (2018)

Ameliorating liver fibrosis in an animal model using the secretome released from miR-122-transfected adipose-derived stem cells
por: Kim, Kee-Hwan, et al.
Publicado: (2019)

Appropriate Hospital Discharge Timing after Laparoscopic Cholecystectomy: Comparison of Postoperative Day 1 vs. Day 2 Discharge Protocol
por: Park, Jae Woo, et al.
Publicado: (2019)

Metformin Potentiates the Anticancer Effect of Everolimus on Cervical Cancer In Vitro and In Vivo
por: Chen, Ya-Hui, et al.
Publicado: (2021)

Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) for Lenvatinib plus Everolimus Versus Everolimus Monotherapy in Patients with Advanced Renal Cell Carcinoma
por: Lee, Chung-Han, et al.
Publicado: (2021)

Characterization of biological responses of colorectal cancer cells to anticancer regimens
por: Roh, Seon Ae, et al.
Publicado: (2012)

Treatment Response and Tolerability of Pegylated Interferon-α Plus Ribavirin Combination Therapy in elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea
por: Kim, Hyeong Il, et al.
Publicado: (2012)

Antioxidant and Angiotensin-Converting Enzyme (ACE) Inhibitory Activities of Yogurt Supplemented with Lactiplantibacillus plantarum NK181 and Lactobacillus delbrueckii KU200171 and Sensory Evaluation
por: Kim, Eun-Deok, et al.
Publicado: (2021)

Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial
por: Kim, Hyung Duk, et al.
Publicado: (2021)

Efficacy and Safety of Everolimus plus Somatostatin Analogues in Patients with Neuroendocrine Tumors
por: Ge, Wenhao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_635j8f268e4vssjuve43kqpuas